Qiu Y, Wu L, Cai W, Chen M, et al. The evolution and prognostic impact of HER2-low, HER2-ultralow, and HER2-null status in HER2-negative early breast cancer: A pre- to post-neoadjuvant chemotherapy study. Cancer 2026;132:e70269.
PMID: 41562542